Clinical Trial Service Partners in New Zealand
The following table provides information on entities in New Zealand involved in clinical trials, including phase, therapeutic area or medical device. For instance, District Health Boards with expertise in conducting Phase II clinical trials in metabolic disorders, or Clinical Research Organisations with capability to manage a Phase I trial in immunology or ability to work on a medical device prototype.
Medicines New Zealand Guidelines on Clinical Trials Compensation for Injury Resulting from Participation in an Industry-Sponsored Clinical Trial
Medicines New Zealand Incorporated favours a simple and expeditious procedure in relation to the provision of compensation for injury caused by participation in clinical trials. Medicines New Zealand recommends, therefore, that a member company sponsoring a clinical trial should, without legal commitment, provide to the investigator - and through him/her to the relevant research ethics committee - a written assurance that the following guidelines will be adhered to in the event of injury caused to a patient that is attributable to participation in the trial in question. These guidelines are an adaptation of those used by the Association of British Pharmaceutical Industry.